🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Brief Summary: 800 RRMS Subjects currently treated with Avonex or Copaxone ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00101959
Treatments Being Tested
The purpose of this study is to determine * whether treatment with Betafer...
Status
Completed
Location
Multiple Locations
Start Date
2003-11
Trial ID
NCT00099502
The primary objective of this study is to compare patient medication satisf...
Status
Completed
Location
Teva Investigational Site 13485
Start Date
2015-08-10
Trial ID
NCT02499900
Treatments Being Tested
This open-label extension study will evaluate the long-term safety of glati...
Status
Completed
Location
Teva Investigational Site 009
Start Date
1994-03-26
Trial ID
NCT00203021
Treatments Being Tested
This study is designed to compare injection skin (injection site) reactions...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00240032
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-06
Trial ID
NCT00451451
Treatments Being Tested
The purpose of this study is to determine if certain drugs commonly used to...
Status
Completed
Location
General Clinical Research Center
Start Date
2007-06
Trial ID
NCT00490906
Treatments Being Tested
This study will investigate the efficacy, safety and tolerability of a new ...
Status
Terminated
Location
Teva Investigational Site 10192
Start Date
2012-03
Trial ID
NCT01578785
Treatments Being Tested
The purpose of this study is to compare pain associated with injections and...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00947752
Treatments Being Tested
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested